• Strategy | Five inflation prints and three MPC meetings left until end of 2025. What to expect? 
• ELEC | 2Q25 weak as expected; growth projects and lower rates underpin outlook
• ABUK | Sector catalyst: potential shift to cash subsidies
• BMIC | El Ashry raises offer, valuation in line with peers

• In today's views
  • Strategy | TALM may be amongst the top performers within defensives over the coming 16 months
  • EGCH | FY24/25 results: strong core performance, but valuation stretched
  • MCRO | Recovery story with strategic optionality 

• Strategy | Five market moving events will likely drive the index towards the 40k mark by end 2025/early 2026
• ORAS | Another solid quarter, backlog growth supports outlook
• EFIC | 1H25 results show significant margin pressure, 3Q25 outlook remains challenging
• CSAG | FY24/25 results resilient; discount to ALCN offers upside opportunity; DCCC revaluation adds further upside
• ACRO | Voluntary delisting: exit price screens modest versus fundamentals
• EKHO | Delta insurance exit gains ECA approval, unlocking c. EGP2.5 billion

In today's Views: 

• Strategy| PHDC to join the list of winners if the CBE opts for a 2% plus rate cut on 28 August.
• ISPH | Arrears inflow to ease working capital; reiterate top pick

In today's Pre-Session Views:

• Strategy | KPIs show that EGAL 4Q NPM compression was driven by a one-off expense/loss.
  NBFI’s | Clear structural winners as Egypt eases monetary policy
• MTIE | Positive developments reaffirm our FV of EGP12.4/share by end-2025; Tata’s manufacturing plans to shape the story thereafter
• DSCW | Volumes drive 2Q25 growth, margins temporarily capped by expansion; but growth outlook intact

• Strategy | A strong EUR triggers aluminum price rally - reiterate long EGAL position
• Healthcare & pharma | Beneficiaries of a potential policy rate cut
• CICH | Earnings momentum builds; Market mispricing persists